Cereno Scientific AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	74.64	127.58	87.17	67.05	89.63
Cash & Short-Term Investments	74.64	127.58	87.17	67.05	89.63
Cash Growth	-41.49%	46.36%	30.01%	-25.20%	35.80%
Other Receivables	1.99	2.88	1.12	1.25	1.36
Total Trade Receivables	1.99	2.88	1.12	1.25	1.36
Other Current Assets	1.72	2.54	0.41	0.33	0.24
Total Current Assets	78.35	133	88.7	68.63	91.24
Net Property, Plant & Equipment	2.88	3.6	0.01	0.03	0.04
Other Intangible Assets	321.44	277.17	196.26	146.99	89.45
Long-Term Investments	0	0.01	0.01	0.01	0.01
Other Long-Term Assets	0	0.01	-	-	-
Total Assets	402.68	413.78	284.99	215.65	180.74
Accounts Payable	10.09	13.95	6.93	9.41	2.88
Accrued Expenses	10.07	5.5	15	3.71	2.35
Short-Term Debt	-	-	-	-	4.8
Other Current Liabilities	4.91	12	1.23	0.62	0.23
Total Current Liabilities	25.08	31.45	23.16	13.74	10.27
Long-Term Debt	125	190.4	45.4	0.4	0.4
Total Long-Term Liabilities	125	190.4	45.4	0.4	0.4
Total Liabilities	150.08	221.85	68.56	14.14	10.67
Common Stock	31.05	28.17	23.38	13.75	10.53
Additional Paid-in Capital	316.2	271.84	299.08	245.73	189.76
Retained Earnings	-94.66	-108.09	-106.04	-57.97	-30.22
Shareholders' Equity	252.6	191.93	216.42	201.51	170.06
Total Liabilities & Equity	402.67	413.77	284.99	215.65	180.74
Total Debt	125	190.4	45.4	0.4	5.2
Net Cash (Debt)	-50.36	-62.82	41.77	66.65	84.43
Net Cash Growth	-	-	-37.33%	-21.07%	49.48%
Net Cash Per Share	-0.15	-0.20	0.18	0.48	0.80
Book Value	252.6	191.93	216.42	201.51	170.06
Book Value Per Share	0.77	0.62	0.95	1.47	1.62
Tangible Book Value	-68.84	-85.24	20.16	54.52	80.62
Tangible Book Value Per Share	-0.21	-0.28	0.09	0.40	0.77